Levodopa-induced dyskinesias in spinocerebellar ataxia type 2

Arch Neurol. 2010 Jan;67(1):114-5. doi: 10.1001/archneurol.2009.291.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / adverse effects
  • Atrophy / etiology
  • Atrophy / pathology
  • Depressive Disorder / chemically induced
  • Dose-Response Relationship, Drug
  • Dyskinesia, Drug-Induced / complications
  • Dyskinesia, Drug-Induced / physiopathology*
  • Dyskinesia, Drug-Induced / psychology
  • Female
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / adverse effects*
  • Magnetic Resonance Imaging
  • Middle Aged
  • Parkinsonian Disorders / drug therapy*
  • Parkinsonian Disorders / etiology*
  • Parkinsonian Disorders / pathology
  • Rhombencephalon / pathology
  • Rhombencephalon / physiopathology
  • Spinocerebellar Ataxias / complications*
  • Spinocerebellar Ataxias / pathology

Substances

  • Antiparkinson Agents
  • Levodopa